University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.
It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.
Can women with newly diagnosed low risk DCIS safely avoid surgery without detriment to their psychological wellbeing and can those patients who do require surgery be identified by pathological and radiological criteria?View Trial
Oesophageal Cancer Clinical and Molecular Stratification Study (OCCAMS): A prospective multicentre trial to determine predictive and prognostic biomarkers and therapeutic targets for Oesophageal and Junctional AdenocarcinomaView Trial
Prevention Harp 2
Prevention Of Post-operative Complications By Using HMG-CoA Reductase Inhibitor In Patients Undergoing One Lung Ventilation For Surgery A multicentre randomised double blind placebo controlled trialView Trial
Emergency Laparotomy and Frailty- a national multi-centre study of frail older surgical patients undergoing emergencyView Trial
A double blind (sponsor open) placebo-controlled stratified parallel group study to evaluate the efficacy and safety of repeat doses of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD).View Trial
The Incidence of Juvenile-onset Systemic Lupus Erythematosus in children and young people and their Access to Care in the UK and Republic of IrelandView Trial
QAW039 vs. placebo in patients with uncontrolled s
A 52 week multicentre randomised doubleblind placebo-controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthmaView Trial
A multi-centre randomised double blind placebo-controlled parallel group trial of the effectiveness of the nocturnal use of a Temperature Controlled Laminar Airflow (TLA) Device (Airsonett) in adults with poorly controlled severe allergic asthsmaView Trial
Safety and efficacy of Belimumab After B cell depletion therapy in systemic LUPUS erythematosusView Trial
A Randomized Open-label Multicenter Phase 3 Study to Compare the Efficacy and Safety of BGB-A317 versus Sorafenib as First-Line Treatment in Patients with Unresectable Hepatocellular CarcinomaView Trial